Philip Bejon/N Engl J Med

A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK Gathuri H Mwaniki P Orindi B Otieno EO Mwakio S Mulemi L Isaaka L Shangala J Saisi M Isinde E Oginga IN Wachira AW Manuthu E Kariuki H Asaava P Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi DM Lusamba W Muthui B Adembesa I Mithi C Sood M Aliyan NA Gituma B Matiko MG Omondi CA Ombajo LA Kirui N Ochola L Abdi AI Kagucia EW English M Hamaluba M Ochola-Oyier I Kamuya D Bejon P Barasa E Agweyu A Akech S Etyang AO
N Engl J Med, (2025). 393:2187-2197

Low-Dose Yellow Fever Vaccine in Adults in Africa.Kimathi D Juan-Giner A Bob NS Orindi B Namulwana ML Diatta A Cheruiyot S Fall G Dia M Hamaluba MM Nyehangane D Karanja HK Gitonga JN Mugo D Omuoyo DO Hussein M Oloo E Kamau N Wafula J Bendera J Silvester N Mwavita J Joshua M Mwendwa J Agababyona C Ngetsa C Aisha N Moki F Buluku T Munene M Mwanga-Amumpaire J Lutwama J Kayiwa J Kamaara E Barrett AD Kaleebu P Bejon P Sall AA Grais RF Warimwe GM Nifty Investigators
N Engl J Med, (2025). 392:788-797

Partial Oral Therapy for Osteomyelitis and Endocarditis. Reply.Scarborough M Rombach I Bejon P
N Engl J Med, (2019). 381:1184

Oral versus Intravenous Antibiotics for Bone and Joint Infection.Li HK Rombach I Zambellas R Walker AS McNally MA Atkins BL Lipsky BA Hughes HC Bose D Kumin M Scarborough C Matthews PC Brent AJ Lomas J Gundle R Rogers M Taylor A Angus B Byren I Berendt AR Warren S Fitzgerald FE Mack DJF Hopkins S Folb J Reynolds HE Moore E Marshall J Jenkins N Moran CE Woodhouse AF Stafford S Seaton RA Vallance C Hemsley CJ Bisnauthsing K Sandoe JAT Aggarwal I Ellis SC Bunn DJ Sutherland RK Barlow G Cooper C Geue C McMeekin N Briggs AH Sendi P Khatamzas E Wangrangsimakul T Wong THN Barrett LK Alvand A Old CF Bostock J Paul J Cooke G Thwaites GE Bejon P Scarborough M Oviva Trial Collaborators
N Engl J Med, (2019). 380:425-436

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.Olotu A Fegan G Wambua J Nyangweso G Leach A Lievens M Kaslow DC Njuguna P Marsh K Bejon P
N Engl J Med, (2016). 374:2519-29

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.Agnandji ST Huttner A Zinser ME Njuguna P Dahlke C Fernandes JF Yerly S Dayer JA Kraehling V Kasonta R Adegnika AA Altfeld M Auderset F Bache EB Biedenkopf N Borregaard S Brosnahan JS Burrow R Combescure C Desmeules J Eickmann M Fehling SK Finckh A Goncalves AR Grobusch MP Hooper J Jambrecina A Kabwende AL Kaya G Kimani D Lell B Lemaitre B Lohse AW Massinga-Loembe M Matthey A Mordmuller B Nolting A Ogwang C Ramharter M Schmidt-Chanasit J Schmiedel S Silvera P Stahl FR Staines HM Strecker T Stubbe HC Tsofa B Zaki S Fast P Moorthy V Kaiser L Krishna S Becker S Kieny MP Bejon P Kremsner PG Addo MM Siegrist CA
N Engl J Med, (2016). 374:1647-60

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.Neafsey DE Juraska M Bedford T Benkeser D Valim C Griggs A Lievens M Abdulla S Adjei S Agbenyega T Agnandji ST Aide P Anderson S Ansong D Aponte JJ Asante KP Bejon P Birkett AJ Bruls M Connolly KM D'Alessandro U Dobano C Gesase S Greenwood B Grimsby J Tinto H Hamel MJ Hoffman I Kamthunzi P Kariuki S Kremsner PG Leach A Lell B Lennon NJ Lusingu J Marsh K Martinson F Molel JT Moss EL Njuguna P Ockenhouse CF Ogutu BR Otieno W Otieno L Otieno K Owusu-Agyei S Park DJ Pelle K Robbins D Russ C Ryan EM Sacarlal J Sogoloff B Sorgho H Tanner M Theander T Valea I Volkman SK Yu Q Lapierre D Birren BW Gilbert PB Wirth DF
N Engl J Med, (2015). 373:2025-2037

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.Olotu A Fegan G Wambua J Nyangweso G Awuondo KO Leach A Lievens M Leboulleux D Njuguna P Peshu N Marsh K Bejon P
N Engl J Med, (2013). 368:1111-20

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.Rts SClinical Trials Partnership Agnandji ST Lell B Fernandes JF Abossolo BP Methogo BG Kabwende AL Adegnika AA Mordmuller B Issifou S Kremsner PG Sacarlal J Aide P Lanaspa M Aponte JJ Machevo S Acacio S Bulo H Sigauque B Macete E Alonso P Abdulla S Salim N Minja R Mpina M Ahmed S Ali AM Mtoro AT Hamad AS Mutani P Tanner M Tinto H D'Alessandro U Sorgho H Valea I Bihoun B Guiraud I Kabore B Sombie O Guiguemde RT Ouedraogo JB Hamel MJ Kariuki S Oneko M Odero C Otieno K Awino N McMorrow M Muturi-Kioi V Laserson KF Slutsker L Otieno W Otieno L Otsyula N Gondi S Otieno A Owira V Oguk E Odongo G Woods JB Ogutu B Njuguna P Chilengi R Akoo P Kerubo C Maingi C Lang T Olotu A Bejon P Marsh K Mwambingu G Owusu-Agyei S Asante KP Osei-Kwakye K Boahen O Dosoo D Asante I Adjei G Kwara E Chandramohan D Greenwood B Lusingu J Gesase S Malabeja A Abdul O Mahende C Liheluka E Malle L Lemnge M Theander TG Drakeley C Ansong D Agbenyega T Adjei S Boateng HO Rettig T Bawa J Sylverken J Sambian D Sarfo A Agyekum A Martinson F Hoffman I Mvalo T Kamthunzi P Nkomo R Tembo T Tegha G Tsidya M Kilembe J Chawinga C Ballou WR Cohen J Guerra Y Jongert E Lapierre D Leach A Lievens M Ofori-Anyinam O Olivier A Vekemans J Carter T Kaslow D Leboulleux D Loucq C Radford A Savarese B Schellenberg D Sillman M Vansadia P
N Engl J Med, (2012). 367:2284-95

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.Rts SClinical Trials Partnership Agnandji ST Lell B Soulanoudjingar SS Fernandes JF Abossolo BP Conzelmann C Methogo BG Doucka Y Flamen A Mordmuller B Issifou S Kremsner PG Sacarlal J Aide P Lanaspa M Aponte JJ Nhamuave A Quelhas D Bassat Q Mandjate S Macete E Alonso P Abdulla S Salim N Juma O Shomari M Shubis K Machera F Hamad AS Minja R Mtoro A Sykes A Ahmed S Urassa AM Ali AM Mwangoka G Tanner M Tinto H D'Alessandro U Sorgho H Valea I Tahita MC Kabore W Ouedraogo S Sandrine Y Guiguemde RT Ouedraogo JB Hamel MJ Kariuki S Odero C Oneko M Otieno K Awino N Omoto J Williamson J Muturi-Kioi V Laserson KF Slutsker L Otieno W Otieno L Nekoye O Gondi S Otieno A Ogutu B Wasuna R Owira V Jones D Onyango AA Njuguna P Chilengi R Akoo P Kerubo C Gitaka J Maingi C Lang T Olotu A Tsofa B Bejon P Peshu N Marsh K Owusu-Agyei S Asante KP Osei-Kwakye K Boahen O Ayamba S Kayan K Owusu-Ofori R Dosoo D Asante I Adjei G Adjei G Chandramohan D Greenwood B Lusingu J Gesase S Malabeja A Abdul O Kilavo H Mahende C Liheluka E Lemnge M Theander T Drakeley C Ansong D Agbenyega T Adjei S Boateng HO Rettig T Bawa J Sylverken J Sambian D Agyekum A Owusu L Martinson F Hoffman I Mvalo T Kamthunzi P Nkomo R Msika A Jumbe A Chome N Nyakuipa D Chintedza J Ballou WR Bruls M Cohen J Guerra Y Jongert E Lapierre D Leach A Lievens M Ofori-Anyinam O Vekemans J Carter T Leboulleux D Loucq C Radford A Savarese B Schellenberg D Sillman M Vansadia P
N Engl J Med, (2011). 365:1863-75

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.Bejon P Lusingu J Olotu A Leach A Lievens M Vekemans J Mshamu S Lang T Gould J Dubois MC Demoitie MA Stallaert JF Vansadia P Carter T Njuguna P Awuondo KO Malabeja A Abdul O Gesase S Mturi N Drakeley CJ Savarese B Villafana T Ballou WR Cohen J Riley EM Lemnge MM Marsh K von Seidlein L
N Engl J Med, (2008). 359:2521-32